期刊
SCANDINAVIAN JOURNAL OF SURGERY
卷 109, 期 1, 页码 18-28出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1457496919900413
关键词
Pancreatic ductal adenocarcinoma; neoadjuvant therapy; neoadjuvant chemotherapy; neoadjuvant chemoradiotherapy; pancreatectomy; borderline resectable; locally advanced; FOLFIRINOX; gemcitabine; nab-paclitaxel
类别
Background and Aims: It has become clear that vein resection and reconstruction for pancreatic ductal adenocarcinoma (PDAC) is the standard of care as supported by multiple guidelines. However, resection of large peri-pancreatic arteries remains debatable. Materials and Methods: This review examines the current state of vascular resection with curative intent for PDAC in the last 5 years. Herein, we consider venous (superior mesenteric vein, portal vein), as well as arterial (superior mesenteric artery, celiac trunk, hepatic artery) resection or both with or without reconstruction. Results: Improvement of multidrug chemotherapy has revolutionized care for PDAC that should shift traditional surgical thinking from an anatomical classification of resectability to a prognostic and biological classification. Conclusion: The present review gives an overview on the results of pancreatectomy associated with vascular resection, with consideration of new perspectives offered by the availability of better systemic therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据